Does Cirrhosis Regress in HCV Liver Transplant Recipients Achieving Sustained Virologic Response in the Era of Direct-Acting Antiviral Agents?

被引：0
|
作者：
Putra, J. [1 ]
Schiano, T. [2 ]
Fiel, M. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Pathol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
150
引用
收藏
页码：261 / 261
页数：1
相关论文
共 50 条
  • [31] Assessment of hepatic fibrosis, portal hemodynamic changes, and disease severity in patients with HCV-related liver cirrhosis after sustained virologic response to direct-acting antiviral drugs (DAAs)
    Waleed Attia Hassan
    Sherif I. Kamel
    Ibrahim Abdel Naby Mahmoud
    Nahed Makhlouf
    Mahmoud Moubark
    Sahar M. Hassany
    Egyptian Liver Journal, 13
  • [32] Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy
    Cartwright, Emily J.
    Pierret, Chloe
    Minassian, Caroline
    Esserman, Denise A.
    Tate, Janet P.
    Goetz, Matthew B.
    Bhattacharya, Debika
    Fiellin, David A.
    Justice, Amy C.
    Lo Re, Vincent
    Rentsch, Christopher T.
    JAMA NETWORK OPEN, 2023, 6 (09) : E2335715
  • [33] Liver transplantation for hepatitis C virus in the era of direct-acting antiviral agents
    Audrey, Coilly
    Raffaele, Bruno
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 361 - 368
  • [34] Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents
    Sawinski, D.
    Kaur, N.
    Ajeti, A.
    Trofe-Clark, J.
    Lim, M.
    Bleicher, M.
    Goral, S.
    Forde, K. A.
    Bloom, R. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (05) : 1588 - 1595
  • [35] The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes
    Axelrod, D. A.
    Schnitzler, M. A.
    Alhamad, T.
    Gordon, F.
    Bloom, R. D.
    Hess, G. P.
    Xiao, H.
    Nazzal, M.
    Segev, D. L.
    Dharnidharka, V. R.
    Naik, A. S.
    Lam, N. N.
    Ouseph, R.
    Kasiske, B. L.
    Durand, C. M.
    Lentine, K. L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (10) : 2473 - 2482
  • [36] Effect of HCV clearance with direct-acting antiviral agents on HCC
    Josep M. Llovet
    Augusto Villanueva
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 561 - 562
  • [37] Prophylaxis of HCV Reinfection and Direct-acting Antiviral Agents During Liver Transplantation Reply
    Gutierrez, Julio A.
    Carrion, Andres
    Bhamidimarri, Kalyan Ram
    Peyton, Adam L.
    LIVER TRANSPLANTATION, 2015, 21 (10) : 1330 - 1330
  • [38] Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C
    Enomoto, Masaru
    Ikura, Yoshihiro
    Tamori, Akihiro
    Kozuka, Ritsuzo
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Fujii, Hideki
    Uchida-Kobayashi, Sawako
    Morikawa, Hiroyasu
    Murakami, Yoshiki
    Kawada, Norifumi
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2018, 6 (09) : 1391 - 1400
  • [39] HCV-positive lymphoma after sustained virological response with direct-acting antiviral agents: The game is not over after HCV eradication
    Rodriguez de Santiago, E.
    Velazquez Kennedy, K.
    Garcia Gonzalez, M.
    Gea Rodriguez, F.
    Tellez Villajos, L.
    Tavio Hernandez, E.
    Albillos, A.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 614 - 615
  • [40] Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
    Toshikuni, Nobuyuki
    GUT AND LIVER, 2017, 11 (03) : 335 - 348
12345